Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 05 2017 - 8:05AM
GAITHERSBURG, Md., Jan. 05, 2017 (GLOBE NEWSWIRE)
-- Novavax, Inc. (Nasdaq:NVAX) today announced that management will
present at the 35th Annual
J.P. Morgan Healthcare Conference.
Presentation details are as follows:
Date: Thursday, January 12, 2017
Time: 9:30 am U.S. Pacific Time
Location: California East room, Westin St. Francis Hotel, San
Francisco
Live webcast: novavax.com, "Investors"/ "Events"
The webcast and replay of the presentation will
also be accessible under the "Investors/Events" section of the
website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M(TM) adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company's website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024